Cite
[Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer]
MLA
Shinobu, Tomochika, et al. “[Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].” Gan to Kagaku Ryoho. Cancerchemotherapy, vol. 48, no. 3, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........593aa5b61e39221ad517d73ed298ce6d&authtype=sso&custid=ns315887.
APA
Shinobu, T., Taichi, K., Nobuaki, S., Shoichi, H., & Hiroaki, N. (2021). [Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer]. Gan to Kagaku Ryoho. Cancerchemotherapy, 48(3).
Chicago
Shinobu, Tomochika, Kuwahara Taichi, Suzuki Nobuaki, Hazama Shoichi, and Nagano Hiroaki. 2021. “[Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].” Gan to Kagaku Ryoho. Cancerchemotherapy 48 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........593aa5b61e39221ad517d73ed298ce6d&authtype=sso&custid=ns315887.